Dr Tripathy on the HER2+ Breast Cancer Treatment Paradigm
Debu Tripathy, MD, discusses the current state of the HER2-positive breast cancer treatment paradigm.
Source: onclive.com
Debu Tripathy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Debu Tripathy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Debu Tripathy Today - Breaking & Trending Today
Vepdegestrant Shows Potential in ESR1-Mutant ER+/HER2– Breast Cancer
Debu Tripathy, MD, highlights the potential role and significance of vepdegestrant in pretreated ER-positive/HER2-negative breast cancer.
Source: onclive.com
Tripathy Outlines Where the HER2+ Early-Stage Breast Cancer Landscape Stands
Debu Tripathy, MD, discusses the current treatment paradigm of HER2-positive breast cancer and highlights unmet needs that remain.
Source: onclive.com
HER2 an 'Actionable Biomarker' in Breast Cancer Subset
At the Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit, an expert explained HER2-positive breast cancer and gave an overview of effective treatment options in this space.
Source: curetoday.com
HER2-Directed Therapies Continue to Shape Improved Breast Cancer Outcomes
Debu Tripathy, MD, provides insights on the management of HER2-positive breast cancer, including the evolving role of trastuzumab in this population.
Source: onclive.com